ActiveG.Information & CommunicationsI.Wholesale & Retail TradeL.Scientific & Technical ServicesCorporate Number: 2010001207054
シード医療製薬株式会社 (Corporate ID: 2010001207054) is a corporation operating in the 情報通信業 sector headquartered in 東京都中央区銀座１丁目１３－８ハビウル銀座１Ｆ. Led by 代表取締役 鈴木梓. Latest operational metrics report capital: ¥96M JPY. Fully registered under Japan's National Tax Agency Qualified Invoice System (Invoice No: T2010001207054). Official contact (03-6228-4858), corporate governance, and multi-year financial statements are openly accessible on Kigyou-list.
「(Company business strengths, flagship services, or recruitment messages will be prioritized and displayed here at the top of your corporate profile)」
Registered address: 東京都中央区銀座１丁目１３－８ハビウル銀座１Ｆ
13-digit Corporate Number "2010001207054" was officially assigned by the National Tax Agency Commissioner with corporate name "シード医療製薬株式会社".
Cross-check reviews, press releases, and compliance background across top Japanese portals.
The official representative phone number for シード医療製薬株式会社 is 03-6228-4858 (FAX: 03-6263-0232). Head office is located at 東京都中央区銀座１丁目１３－８ハビウル銀座１Ｆ. Verified contact channels and executive directories are accessible on Kigyou-list.
シード医療製薬株式会社's official 13-digit National Tax Agency Corporate Number is 2010001207054. It is officially registered as a Qualified Invoice Issuer under Japan's consumption tax invoice system with registration ID T2010001207054.
シード医療製薬株式会社 is officially registered and headquartered at Postal Code 1040061, 東京都中央区銀座１丁目１３－８ハビウル銀座１Ｆ. Complete regional jurisdiction and legal relocation history are verified via Japan's National Tax Agency.
Outreach to シード医療製薬株式会社 or acquire targeted lookalike company datasets.
シード医療製薬株式会社に関連する公的異動登記および東京都の各カテゴリ別データベースへの直通インデックスです。 最新の法人登記データや採用活動の動向を各ハブにて毎日自動更新しています。
The official representative of シード医療製薬株式会社 is 代表取締役 鈴木梓, with a registered capital of ¥96M JPY. It is privately held.
On Kigyou-list, users can review verified financial metrics, legal registry history, corporate signals (hiring, subsidies, trademarks), and export standardized CSV datasets for B2B intelligence.